These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20232033)

  • 1. [Therapeutic monoclonal antibodies in clinical neurology].
    Buttmann M; Wiendl H
    Nervenarzt; 2010 Jun; 81(6):753-64; quiz 765-6. PubMed ID: 20232033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in the treatment of multiple sclerosis.
    Di Pauli F; Berger T; Reindl M
    Curr Med Chem; 2009; 16(36):4858-68. PubMed ID: 19929782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic monoclonal antibodies: update on the risk of opportunistic infections].
    Rigal E; Gateault P; Lebranchu Y; Hoarau C
    Med Sci (Paris); 2009 Dec; 25(12):1135-40. PubMed ID: 20035693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological treatment of multiple sclerosis].
    Sørensen PS; Sellebjerg F
    Ugeskr Laeger; 2008 Jun; 170(24):2156-9. PubMed ID: 18565303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating multiple sclerosis with monoclonal antibodies.
    Buttmann M; Rieckmann P
    Expert Rev Neurother; 2008 Mar; 8(3):433-55. PubMed ID: 18345973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities and risks of the monoclonal antibody alemtuzumab as a new treatment option for multiple sclerosis].
    Warnke C; Kieseier BC; Zettl U; Hartung HP
    Nervenarzt; 2009 Apr; 80(4):468-74. PubMed ID: 19296065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis.
    Trebst C; Voss E; Skripuletz T; Stangel M
    Curr Med Chem; 2010; 17(7):640-50. PubMed ID: 20088763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging monoclonal antibody therapies for multiple sclerosis.
    Cree B
    Neurologist; 2006 Jul; 12(4):171-8. PubMed ID: 16832236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies in neurology].
    Jedidi Z; Jedidi H; Moonen G; Belachew S
    Rev Med Liege; 2009; 64(5-6):305-9. PubMed ID: 19642464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opportunistic infections after treatment with monoclonal antibodies].
    Cornely OA; Ullmann AJ; Karthaus M
    Wien Med Wochenschr; 2004 May; 154(9-10):209-17. PubMed ID: 15244046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of new therapies for multiple sclerosis].
    Holmøy T; Celius EG
    Tidsskr Nor Laegeforen; 2011 May; 131(8):832-6. PubMed ID: 21556088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment].
    Bauduer F
    Presse Med; 2009 Jan; 38(1):140-2. PubMed ID: 19004611
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alemtuzumab in early multiple sclerosis].
    Killestein J; Polman CH
    Ned Tijdschr Geneeskd; 2009 Jan; 153(1-2):46. PubMed ID: 19198214
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis - established and novel therapeutic approaches.
    Ehling R; Berger T; Reindl M
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):3-15. PubMed ID: 20236038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular targeted therapy for neuroimmunological diseases].
    Nakashima I
    Brain Nerve; 2013 Nov; 65(11):1353-61. PubMed ID: 24200613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious toxicity using alemtuzumab.
    Nosari A; Montillo M; Morra E
    Haematologica; 2004 Dec; 89(12):1415-9. PubMed ID: 15590388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoclonal antibodies in [corrected] development in [corrected] multiple sclerosis].
    Sastre-Garriga J; Montalban X
    Neurologia; 2011 Nov; 26(9):556-62. PubMed ID: 21481981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic monoclonal antibodies].
    Geissler M; Blum HE
    Dtsch Med Wochenschr; 2000 Dec; 125(49):1501-4. PubMed ID: 11149212
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
    Gasperini C; Haggiag S; Ruggieri S
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1243-53. PubMed ID: 23855792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies in the treatment of leukemia.
    O'Brien S; Albitar M; Giles FJ
    Curr Mol Med; 2005 Nov; 5(7):663-75. PubMed ID: 16305492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.